Metraipolis › archive › dc_aeada41dcbe9

Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient… — Europe PMC PMID:41286338

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41286338
DOI: 10.1038/s41598-[numero omesso]-6
License (as archived): solo-consultazione
Archived: 2026-11-08T07:16:35.197Z
SHA-256 of the archived text: 16a65379e5c8760289bb503e051869ca7a94d711a24c12102147b64c9a540372
Stable URL of this page: https://metraipolis.com/documento/dc_aeada41dcbe9

How to cite

Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient… — Europe PMC PMID:41286338 — Europe PMC (en), https://europepmc.org/article/MED/41286338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aeada41dcbe9 (Metraipolis archive dc_aeada41dcbe9, sha256 16a65379e5c8760289bb503e051869ca7a94d711a24c12102147b64c9a540372)

BibTeX

@misc{dcaeada41dcbe9,
  title = {Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient… — Europe PMC PMID:41286338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41286338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aeada41dcbe9; sha256 16a65379e5c8760289bb503e051869ca7a94d711a24c12102147b64c9a540372},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41286338. Agents can read the archived copy with the MCP tool read_document.